
Tenlitus M 500mg/20mg Tablet SR
Marketer
Fawn Incorporation
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Tenlitus M 500mg/20mg Tablet SR
Diabexe Duo 500mg/20mg Extended-Release Tablets combine two active ingredients to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate the risk of severe diabetic complications, including renal impairment and vision loss, and may lessen the likelihood of cardiovascular events. Diabexe Duo may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal therapeutic outcomes are achieved when coupled with a balanced diet and consistent physical activity. Dosage is individualized based on your health status, glycemic control, and other concurrent medications. Ingesting the tablets with meals helps minimize gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under your physician's guidance. This medication actively contributes to glycemic management and the prevention of long-term complications. Adherence to your prescribed diet and exercise plan is crucial for successful diabetes management. Lifestyle modifications are integral to overall diabetes control. Commonly reported adverse effects include nausea, vomiting, diarrhea, abdominal discomfort, and headache. Hypoglycemia is a potential side effect, particularly when used with insulin or sulfonylureas; proper identification and treatment of hypoglycemia is essential. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption. Pregnant or lactating women require medical consultation before initiating treatment. Potential drug interactions exist; disclose all medications to your doctor to ensure treatment safety. Alcohol should be minimized due to its potential to lower blood glucose. Your doctor will monitor kidney function and blood glucose levels throughout treatment.
Uses of Tenlitus M 500mg/20mg Tablet SR
Managing type 2 diabetes
Major Benefits of Tenlitus M 500mg/20mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tenlitus M 500mg/20mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this extended-release tablet with a meal.
Common Side effects of Tenlitus M 500mg/20mg Tablet SR:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Tenlitus M 500mg/20mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tenlitus M 500mg/20mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Tenlitus M 500mg/20mg Tablet SR works:
Each Tenlitus M 500mg/20mg sustained-release tablet contains a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Tenlitus M 500mg/20mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Tenlitus M 500mg/20mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Tenlitus M 500mg/20mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Tenlitus M 500mg/20mg Tablet SR's effect on driving ability is unknown. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Tenlitus M 500mg/20mg extended-release tablets require careful administration in individuals with impaired kidney function. Dosage modification of Tenlitus M 500mg/20mg extended-release tablets may be necessary. Physician consultation is recommended. For patients exhibiting severe kidney disease, Tenlitus M 500mg/20mg extended-release tablets are contraindicated. Routine monitoring of renal function is advised during treatment.
LiverUNSAFE
The use of Tenlitus M 500mg/20mg SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Tenlitus M 500mg/20mg Tablet SR :
Should you forget to take a Tenlitus M 500mg/20mg sustained-release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tenlitus M 500mg/20mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
